Ann W. Gramza, M.D.
Ann W. Gramza, M.D.
Staff Clinician

Center for Cancer Research
National Cancer Institute

Building 10, Room 12N226
Bethesda, MD 20892
301-827-4989

Her translational laboratory research focused on the molecular genetics of thyroid malignancies, in particular as targets for therapeutic agents. She is currently in pursuit of translational clinical research studies of new therapeutics for patients with thyroid malignancies.

Areas of Expertise
thyroid malignancies, therapeutic agents
Selected Publications
  1. Smallridge RC, Copland JA, Brose MS, Wadsworth JT, Houvras Y, Menefee ME, Bible KC, Shah MH, Gramza AW, Klopper JP, Marlow LA, Heckman MG, Von Roemeling R.
    J. Clin. Endocrinol. Metab.. 98: 2392-400, 2013. [ Journal Article ]
  2. Sosa JA, Elisei R, Jarzab B, Balkissoon J, Lu S, Bal C, Marur S, Gramza A, Ben-Yosef R, Gitlitz B, Haugen BR, Ondrey F, Lu C, Karandikar S, Khuri F, Licitra L, Remick SC.
    Thyroid. 24: 232-40, 2013. [ Journal Article ]
  3. Gramza A, Kebebew E.
    Nat Rev Endocrinol. 8: 454-5, 2012. [ Journal Article ]
  4. Sosa JA, Balkissoon J, Lu SP, Langecker P, Elisei R, Jarzab B, Bal CS, Marur S, Gramza A, Ondrey F.
    Surgery. 152: 1078-87, 2012. [ Journal Article ]
  5. Gramza A, Schuff KG.
    Onco Targets Ther. 1: 87-101, 2009. [ Journal Article ]

Dr. Gramza received her M.D. from The Ohio State University in 2000. She completed clinical training in internal medicine and palliative care at the University of New Mexico in 2004 and fellowships in hematology and oncology at Oregon Health and Sciences University (OHSU) in 2007. Upon completion of her fellowship training, she was appointed to assistant professor of medicine in the Division of Hematology and Medical Oncology at OHSU and the Portland Veterans Affairs Medical Center, where her translational laboratory research focused on the molecular genetics of thyroid malignancies, in particular as targets for therapeutic agents. She joined the Medical Oncology Branch, NCI in 2010 to continue her pursuit of translational clinical research studies of new therapeutics for patients with thyroid malignancies. In 2012, she joined the Endocrine Oncology Branch, NCI.

Summary

Her translational laboratory research focused on the molecular genetics of thyroid malignancies, in particular as targets for therapeutic agents. She is currently in pursuit of translational clinical research studies of new therapeutics for patients with thyroid malignancies.

Areas of Expertise
thyroid malignancies, therapeutic agents

Clinical Trials

Publications

Selected Publications
  1. Smallridge RC, Copland JA, Brose MS, Wadsworth JT, Houvras Y, Menefee ME, Bible KC, Shah MH, Gramza AW, Klopper JP, Marlow LA, Heckman MG, Von Roemeling R.
    J. Clin. Endocrinol. Metab.. 98: 2392-400, 2013. [ Journal Article ]
  2. Sosa JA, Elisei R, Jarzab B, Balkissoon J, Lu S, Bal C, Marur S, Gramza A, Ben-Yosef R, Gitlitz B, Haugen BR, Ondrey F, Lu C, Karandikar S, Khuri F, Licitra L, Remick SC.
    Thyroid. 24: 232-40, 2013. [ Journal Article ]
  3. Gramza A, Kebebew E.
    Nat Rev Endocrinol. 8: 454-5, 2012. [ Journal Article ]
  4. Sosa JA, Balkissoon J, Lu SP, Langecker P, Elisei R, Jarzab B, Bal CS, Marur S, Gramza A, Ondrey F.
    Surgery. 152: 1078-87, 2012. [ Journal Article ]
  5. Gramza A, Schuff KG.
    Onco Targets Ther. 1: 87-101, 2009. [ Journal Article ]

Biography

Dr. Gramza received her M.D. from The Ohio State University in 2000. She completed clinical training in internal medicine and palliative care at the University of New Mexico in 2004 and fellowships in hematology and oncology at Oregon Health and Sciences University (OHSU) in 2007. Upon completion of her fellowship training, she was appointed to assistant professor of medicine in the Division of Hematology and Medical Oncology at OHSU and the Portland Veterans Affairs Medical Center, where her translational laboratory research focused on the molecular genetics of thyroid malignancies, in particular as targets for therapeutic agents. She joined the Medical Oncology Branch, NCI in 2010 to continue her pursuit of translational clinical research studies of new therapeutics for patients with thyroid malignancies. In 2012, she joined the Endocrine Oncology Branch, NCI.